Skip to main content
OpenTrials

Clinical trial condition

Biliary Tract Cancer

Explore clinical trials studying Biliary Tract Cancer. Study availability and eligibility vary by location and protocol.

168 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Biliary Tract Cancer trial results

Recruiting

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

NCT06428409

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +13 more
Locations
  • UCLA ( Site 0317) Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus ( Site 0299) Aurora, Colorado, United States
  • University of Colorado Anschutz Medical Campus ( Site 0325) Aurora, Colorado, United States
  • University of Colorado Anschutz Medical Campus ( Site 0326) Aurora, Colorado, United States
View all 55 locations
View Trial Details
Recruiting

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

NCT06282575

Conditions
Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +11 more
Locations
  • City of Hope(City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • Rocky Mountain Cancer Centers, LLP Lone Tree, Colorado, United States
  • AdventHealth Hematology and Oncology Orlando, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 185 locations
View Trial Details
Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

NCT06293898

Conditions
Adnexal Diseases, Biliary Tract Cancer, Biliary Tract Diseases, +51 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Cedars Sinai Los Angeles, California, United States
  • Scripps Health San Diego, California, United States
View all 26 locations
View Trial Details
Recruiting

CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence

NCT06037980

Conditions
Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +9 more
Locations
  • Ospedali Riuniti di Ancona Ancona, Italy
  • ASST Papa Giovanni XXIII Bergamo, Italy
  • Oncologia Medica Policlinico Sant'Orsola - Malpighi Bologna, Italy
  • ASST Spedali Civili Brescia, Italy
View all 19 locations
View Trial Details
Recruiting

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

NCT06774963

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Biliary Tract Cancer, +37 more
Locations
  • Hoag Family Cancer Institute Newport Beach, California, United States
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University, Siteman Cancer Center St Louis, Missouri, United States
View all 14 locations
View Trial Details
Recruiting

AB122 Platform Study

NCT04999761

Conditions
Advanced or Metastatic Solid Tumor, Alveolar Soft Part Sarcoma, Biliary Tract Cancer, +41 more
Locations
  • A site selected by Taiho Pharmaceutical Co., Ltd. Aichi, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Chiba, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Ehime, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Hokkaido, Japan
View Trial Details

Related conditions